EUVIMEDEUVIMED entdecken
LeserbriefOpen Access

Manidipine is not a potential inhibitor against SARS-CoV-2 main protease

Rui Zhang, Jiahao Zhou, Haohao Yan, Xiaoping Liu, Chao Shang iD, Yunyu Chen iD

Antimicrobial Agents and Chemotherapy · 2024

DOI: 10.1128/aac.01297-23 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2024. Verfasst von Rui Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Drug Screening and Evaluation, Wannan Medical College, Wuhu, China. Hauptthemen laut MEDLINE: COVID-19, Dihydropyridines, Nitrobenzenes, Piperazines. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: University Natural Science Research Project of Anhui Province, The Young Fellow Program of Wannan Medical College, China, Postgraduate Academic Innovation Program of Anhui Province, China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19DihydropyridinesNitrobenzenesPiperazinesHumansSARS-CoV-2Coronavirus 3C ProteasesProtease InhibitorsMolecular Docking Simulation

Stichwörter der Autor:innen

COVID-19SARS-CoV-2fluorescence polarizationmain protease inhibitormanidipine

Substanzen

3C-like proteinase, SARS-CoV-2manidipineCoronavirus 3C ProteasesProtease InhibitorsDihydropyridinesNitrobenzenesPiperazines

Autor:innen und Institutionen

  • Institute for Drug Screening and Evaluation, Wannan Medical College, Wuhu, China.
  • Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, China.

ORCID-Profile: Chao Shang, Yunyu Chen

Förderung

  • University Natural Science Research Project of Anhui Province
  • The Young Fellow Program of Wannan Medical College, China
  • Postgraduate Academic Innovation Program of Anhui Province, China

Zitieren

APA

Zhang, R., Zhou, J., Yan, H., Liu, X., Shang, C., & Chen, Y. (2024). Manidipine is not a potential inhibitor against SARS-CoV-2 main protease. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01297-23

Vancouver

Zhang R, Zhou J, Yan H, Liu X, Shang C, Chen Y. Manidipine is not a potential inhibitor against SARS-CoV-2 main protease. Antimicrobial Agents and Chemotherapy. 2024. doi:10.1128/aac.01297-23

BibTeX
@article{Zhang2024,
  author = {Zhang, Rui and Zhou, Jiahao and Yan, Haohao and Liu, Xiaoping and Shang, Chao and Chen, Yunyu},
  title = {Manidipine is not a potential inhibitor against SARS-CoV-2 main protease},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2024},
  doi = {10.1128/aac.01297-23}
}
Kostenlos starten →